Restructuring Roche's R&D: An Interview with Lee Babiss

Even though Roche has been the single most successful investment in Big Pharma--because Roche has been the single most successful investor in Big Pharma--productivity over the past few years was slowed by leadership bottlenecks, misalignment among functions, and roadblocks to creativity. Roche's brand-new research boss, Lee Babiss, says a new decentralized structure and a more aggressive out-partnering strategy is designed to address the issues, manage risk, and spur post-2015 growth